ASPIC

Virtual event, Worldwide

5 - 6 October, 2021

See more informations here: https://www.eacr.org/conference/goodbyeflatbiology2021virtual?utm_source=eacrnews&utm_medium=email&utm_campaign=vGFB21&utm_content=

Virtual Event, Worldwide

29 - 30 June, 2021

See more informations here: https://www.eacr.org/conference/imagingcancer2021?utm_source=eacrnews&utm_medium=email&utm_campaign=vIMG21&utm_content=

Virtual Event, Worldwide

29 - 30 June, 2021

See more informations here: https://www.eacr.org/conference/imagingcancer2021?utm_source=eacrnews&utm_medium=email&utm_campaign=vIMG21&utm_content=

Virtual Event, Worldwide

18 - 19 May 2021

See more informations here: https://www.eacr.org/conference/Bioinformatics2021virtual?utm_source=eacrnews&utm_medium=email&utm_campaign=vBIO21&utm_content=banner

Virtual Event, Worldwide

18 - 19 May 2021

See more informations here: https://www.eacr.org/conference/Bioinformatics2021virtual?utm_source=eacrnews&utm_medium=email&utm_campaign=vBIO21&utm_content=banner

Autores e Afiliações:

Giacomo Domenici ^1,2 Rodrigo Eduardo 1,2 Helena Castillo-Ecija ³ Gorka Orive ^4,5 Ángel Montero Carcaboso ³ Catarina Brito ^1,2

¹-iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal

²-Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal

Authors and Affiliations:

Cristina Amaral, Fabien Marc Trouille, Cristina Ferreira Almeida, Georgina Correia-da-Silva, Natércia Teixeira

UCIBIO.REQUIMTE, Laboratório de Bioquímica, Faculdade de Farmácia, Universidade do Porto

Abstract:

Autores e Afiliações:

Cristina Amaral, Fabien Marc Trouille, Cristina Ferreira Almeida, Georgina Correia-da-Silva, Natércia Teixeira

UCIBIO.REQUIMTE, Laboratório de Bioquímica, Faculdade de Farmácia, Universidade do Porto

Abstract:

Breast cancer is a heterogeneous disease, composed of different subtypes. However, there are no real-world data on the cost of treatment according to these different subtypes. This study aimed to estimate the direct medical costs of diagnosing and treating early breast cancer in the first 3 years after diagnosis according to subtype and stage.

We included 703 women with early breast cancer, newly diagnosed, admitted in 2012 to the Portuguese Institute of Oncology in Porto, who were prospectively followed in the NEON-BC cohort.